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Two cases of women in their thirties with past histories of atopic dermatitis and allergic rhinitis developed a low grade fever,
followed by a butterﬂy-shaped erythema, swelling of their ﬁngers, and polyarthralgia. Despite such symptoms that overlap with
those of systemic lupus erythematosus (SLE), the diagnostic criteria for SLE were not fulﬁlled. Due to positive results for human
parvovirus B19 (HPV-B19) IgM antibodies in the serum, diagnoses of HPV-B19 infection were made in both cases. Although
acetaminophen failed to improve their deteriorating symptoms, a nonsteroidal anti-inﬂammatory drug (NSAID), loxoprofen,
completely removed the symptoms immediately after the administration. In those cases, since the patients were predisposed to
atopic disorders, an increased immunological response based on the lymphocyte hypersensitivity was likely to be involved in the
pathogenesis. The immunomodulatory property of NSAID was thought to repress such lymphocyte activity and thus provided a
rapid and sustained remission of the disease.
1.Introduction
The classic symptoms of human parvovirus B19 (HPV-B19)
infection include fever, rash, arthralgia, and edema [1]. In
children, the symptoms are usually self-limited, resolving
spontaneously within a few weeks [2]. In adults, however,
they are often prolonged, sometimes causing serious com-
plications, such as chronic arthritis, myocarditis, and menin-
gitis [3–5], or triggering the onset of autoimmune diseases
[6]. According to previous studies, the direct cytotoxicity
of the virus has been ascribed to the pathogenesis of the
symptoms [7, 8]. However, due to the absence of drugs that
are eﬀective for the virus, there is no causal treatment. To
relieve the symptoms, analgesics or antipyretics are generally
used [9], although they do not shorten the duration of
the disease. Here, we experienced two cases of HPV-B19
infection in adult patients with past histories of atopic
dermatitis and allergic rhinitis. In those cases, due to
the atopic predispositions of the patients, an increased
immunologicalresponsewasmorelikelytobeinvolvedinthe
pathogenesis of the symptoms. In such cases, a nonsteroidal
anti-inﬂammatory drug (NSAID), loxoprofen, dramatically
improved their deteriorating symptoms immediately after
the administration. The immunomodulatory property of
this drug was thought to repress the lymphocyte activity,
and thus provided a rapid and sustained remission of the
disease.
2. Case Presentation
2.1. Case 1. A 38-year-old woman with a childhood history
of atopic dermatitis and allergic rhinitis came to our
outpatient clinic because of polyarthralgia and swelling of
her ﬁngers. Five days prior to her visit, she had upper
respiratory symptoms and a low grade fever (Figure 1).
Oraladministration of400mgacetaminophenrelievedthose
symptoms. Then, however, she developed a butterﬂy-shaped
erythema on her face and swelling of her ﬁngers. Three
days later, although the facial erythema had improved, she
developed joint pain in her ﬁngers, wrists, shoulders, and
knees, for which acetaminophen did not work. On physical2 Case Reports in Medicine
examination, the patient looked tired. Her body temperature
was 36.7◦C, blood pressure was 94/50mmHg, and pulse rate
was61beats/min.Sheweighed48kgandwas153cmtall.She
hadnorashexceptforamalarerythemathatwasfaintatthat
time. All her ﬁngers were swollen, but her wrist, shoulder,
and knee joints were not. Both her legs had pretibial
pitting edema. Laboratory data showed mild hypopro-
teinemia (serum protein 6.4g/dL) and slightly decreased
peripheralwhiteblood cellcount(4,100/µL).H o w ev e r ,othe r
hematologic parameters were relatively normal (hemoglobin
11.2g/dL, hematocrit 35.2%, reticulocyte 1.4%, and platelet
count 230,000/µL). Liver enzymes and C-reactive protein
levels were not elevated. Regardless of hypocomplementemia
(C3 72mg/dL, C4 9mg/dL, and CH50 18.6 U/mL), the
tests for serum antinuclear antibodies and rheumatoid
factor were negative. Althoughthe IgG antibody was not
examined, a positive result for HPV-B19 IgM antibody
(index 7.97) indicated a recent infection of the virus [10].
Since microbiological tests for other viruses, such as measles
and rubella, were negative, a diagnosis of HPV-B19 infection
wasﬁnallymade.Becausehersymptomsdeteriorateddespite
the use of acetaminophen, oral administration of loxoprofen
(180mg/day) was alternatively started immediately after
the diagnosis (Figure 1). The symptoms, including facial
erythema, polyarthralgia, and the swelling of her ﬁngers,
rapidly disappeared within 12 hours after the initiation of
the drug. No recurrence of the symptoms or signs was noted
afterwards, indicating the complete remission of the disease.
2.2. Case 2. A 36-year-old woman with a past history of
allergic rhinitis came to our outpatient clinic because of
polyarthralgia and swelling of her ﬁngers. Ten days prior to
her visit, she had a low grade fever (Figure 2)w h e nh e r9 -
year-old son was diagnosed as having erythema infectiosum
because of his slapped cheek rash. Seven days later, she
developed a butterﬂy-shaped erythema transiently on her
face that disappeared the next day. Then, she developed
swellingofherﬁngersandjointpaininhershoulders,ankles,
and knees. Since oral administration of acetaminophen did
not relieve her symptoms, she came to our clinic. On
physical examination, the patient looked tired. Her body
temperature was 37.0◦C, blood pressure was 110/72mmHg,
and pulse rate was 66 beats/min. She weighed 52kg and
was 160cm tall. At that time, she presented no malar
erythema and no rash in her body. Although all her ﬁngers
were swollen, the swelling of her shoulder, ankle, and knee
joints was not obvious. Laboratory data showed normal
hematologic parameters (white blood cell count 6,300/µL,
hemoglobin 12.6g/dL, hematocrit 37.6%, and platelet count
264,000/µL). Liver enzymes and C-reactive protein levels
were not elevated. Due to a positive result for HPV-B19
IgM antibody in the serum (index 8.20) and the preceding
infection of her son, a diagnosis of HPV-B19 infection
was made. Oral administration of loxoprofen (180mg/day)
was immediately started after the diagnosis (Figure 2). Her
deteriorating symptoms, including polyarthralgia and the
swelling of her ﬁngers, quickly disappeared within 12 hours
after the initiation of the drug.
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Figure 1: Clinical course of Case 1. Five days prior to her visit,
the patient had upper respiratory symptoms and a low grade
fever. Then, she developed a butterﬂy-shaped erythema, swelling of
her ﬁngers, and polyarthralgia. Immediately after the initiation of
loxoprofen, the symptoms rapidly disappeared within 12 hours. No
recurrence of the symptoms or signs was noted afterwards. ACA,
acetaminophen.
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Figure 2: Clinical course of Case 2. Ten days prior to her
visit, the patient had a low grade fever. Seven days later, she
developed a butterﬂy-shaped erythema, followed by swelling of
her ﬁngers and polyarthralgia. Immediately after the initiation of
loxoprofen, the symptoms quickly disappeared within 12 hours.
Therewas norecurrenceofthesymptomsorsignsafterwards. ACA,
acetaminophen.
3. Discussion
Skin rashes and arthralgia are the most common clinical
features in adult patients with HPV-B19 infection [1]. Previ-
ous studies have ascribed the pathogenesis of the symptoms
to the direct cytotoxicity of the virus [7, 8]. In our cases,
however, it was less likely involved, because both patients
developed the symptoms in the absence of reticulocytopenia
or thrombocytopenia that usually coincides with viremia
[11, 12]. Although their clinical and laboratory features
did not fulﬁll the diagnostic criteria for systemic lupus
erythematosus (SLE) [13], their SLE-like features, includ-
ing butterﬂy-shaped erythema and polyarthralgia, strongly
suggestedanincreasedimmunologicalresponse.Inaddition,
hypocomplementemia in Case 1, which occurs in both SLE
and HPV-B19 infection [14], indicated the activation of
the classical complement pathway caused by the increase inCase Reports in Medicine 3
immune complexes. Therefore, in our cases, such enhanced
immunity was more likely to be involved in the pathogenesis
of the symptoms. According to previous studies, patients
with atopic dermatitis and allergic rhinitis are prone to
develop autoimmune diseases due to the hypersensitivity of
T-helper 2 lymphocytes [15, 16] or the dysregulated activity
of B-lymphocytes [17]. In our cases, since both patients were
predisposedtoatopicdisorders,suchasatopicdermatitisand
allergic rhinitis, the HPV-B19 infection may have triggered
the activity of the lymphocytes.
For adult patients with HPV-B19 infection, NSAIDs are
often used to provide symptomatic relief for arthralgia and
myalgia [12, 18]. However, since these drugs do not shorten
the duration of the disease, the patients have to wait at least
1 to 2 weeks for the spontaneous remission of the disease
[19, 20]. In our cases, although acetaminophen failed to
ameliorate the patients’ symptoms, loxoprofen completely
removed their deteriorating symptoms quickly after the
administration (Figures 1 and 2). Therefore, in our cases,
loxoprofen was thought to be responsible for the complete
remission of the disease. NSAIDs are the most commonly
used anti-inﬂammatory, analgesic, and antipyretic drugs.
Additionally, due to their immunomodulatory properties
[21], they have also been used in the treatment of autoim-
mune diseases, such as SLE [22] and rheumatoid arthri-
tis [23]. Studies have revealed that NSAIDs inhibit the
migration of leukocytes or their cytokine production, either
cyclooxygenase (COX) dependently [24] or independently
[25, 26], and thus exert immunomodulatory eﬀects. In the
present cases, since the increased activity of lymphocytes was
mainly involved in the pathogenesis, the immunomodula-
tion by the NSAID was thought to be responsible for the
rapid removal of the symptoms and the complete remission
of the disease. Recently, we have demonstrated in a basic
study that NSAIDs repress the activity of lymphocytes by
the functional inhibition of delayed rectiﬁer K+-channels
(Kv1.3) [27]. Since T-lymphocytes highly express the chan-
nels in their plasma membranes [28], such mechanism
may have greatly contributed to the immunomodulatory
eﬀect of NSAID in our patients. In this regard, besides the
short-term use of immunosuppressive agents or steroids,
the use of selective Kv1.3-channel blockers may also be
useful. The early administration of such drugs would not
only shorten the duration of the disease, but also prevent
the serious complications caused by HPV-B19 infection
or the onset of autoimmune diseases triggered by the
virus.
In summary, this is the ﬁrst report of HPV-B19 infec-
tion in adult patients with atopic predispositions showing
the usefulness of NSAID for the quick removal of the
symptoms. The immunomodulatory property of NSAID
was thought to repress the increased lymphocyte activity
and thus provided a rapid and sustained remission of the
disease.
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